Akorn (AKRX -0.4%) has reportedly received FDA approval for its generic version of of Allergan's...

|By:, SA News Editor

Akorn (AKRX -0.4%) has reportedly received FDA approval for its generic version of of Allergan's (AGN) Alocril, a prescription eye drop for itchy allergy eyes.